02 9487 9111
 

Sydney Adventist Hospital
« View pages

Our Services

News

25 Feb 2019

ARI photobiomodulation trial featured on ABC News

Dr Ann Liebert Director of Photomolecular Research at the San's research arm the Australasian Research Institute (ARI) has been interviewed for an ABC TV News report.

It reports on research on the use of Photobiomodulation Therapy for the treatment of degenerative diseases such as Parkinson's disease.

Photobiomodulation is a low-level light therapy, which by using red or near-infrared light may stimulate, heal, regenerate and protect injured or degenerating tissue. It is currently being used in human trials in South Australia and has been used by a small group of people in Tasmania to treat their Parkinson's symptoms.

Following her role as a lead investigator in the South Australia trials, Dr Liebert will soon be leading the first NSW trial at the ARI.

The trial involves Liisa Laakso from Griffith University, San cardiologist Professor Hosen Kiat, Dr Brian Bicknell from the ARI, Professor John Mitrofanis from Sydney University, Sharon Tilley from Lymphoedema Education Solutions and research assistant Angela Toresi. The study is funded by Parkinson's South Australia.

The interview with ABC TV Tasmania discusses current trials which are designed to test if photobiomodulation can slow the progression of symptoms of Parkinson's disease.

 

 

Click here for the 7pm news bulletin

Click here for the ABC article

 

    


« Back to News Room

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services